PATENT CLAIM ANALYSIS

Application Number: 15772887
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "303000"]

Abstract:
There are provided compounds of formula I, wherein X, Ak, s, A, R 1  and R 2  have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of the JAK family) and have use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, eye and intestines.

Claim (Index 4):
A compound as claimed in  claim 1 , wherein:\n R 1  and R 2  independently represent H, heterocyclyl, C 1-2  alkyl or phenyl, which latter two groups are optionally substituted by one or more substitutents selected from heterocyclyl, halo, cyano, \u2014OR 5a  and methyl, which latter group is optionally substituted by one or more halo atoms; and R 5a  represents H or C 1-2  alkyl.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13542153', '14041387', '12824845', '14384508', '15341226']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.826536884877622
- 35 USC 102 Novelty (BERT): 0.5695753565070406
- Combined Prediction Score: 0.8008407320405638
- Mean Citation Score: 417.2993
- Max Citation Score: 453.0432
- Similarity Product: 381.384877871704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test